Seeking Alpha
View as an RSS Feed

Spencer Osborne  

View Spencer Osborne's Comments BY TICKER:
Latest  |  Highest rated
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    Jakes...

    I am not ruthless in trading, nor would I say the way I trade is ruthless, let alone the mist ruthless.

    I do not short stocks. I do not pump. I do not bash. Do not let my investment dictate what I write nor let it blind my opinion.

    I follow fundamentals, technicals, and psychology.

    If I see an opening that I feel I will benefit from I try it.

    Vivus...fundamentals are not there. Technicals are not there. Psychology is not there. That tells there is no hurry to make a play.
    May 1, 2015. 04:46 PM | Likes Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    Jakes....

    I like how you seem to think you know why I invested.

    I invested after approval anticipating that there would simply be demand high enough to send the stock up.

    I have long stated that diet and exercise is the best way to control weight.

    In my estimation probably at least 75% of ties that qualify for the drug could accomplish the needed weight loss by taking personal responsibility.

    You say I wanted to make a quick buck....I say F$&@ You.

    Done
    May 1, 2015. 03:38 PM | Likes Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    Jakes....

    Actually, I have said this before, I like Belviq for the smoking cessation aspect. When the drug did not take off, I sold half of that position. I took a late 2014 flyer on a good beginning to 2015. When that did not pan out I trimmed that over core position in the past couple of months.

    My investment in orex is related to the European approval and possible partnership.
    May 1, 2015. 02:56 PM | Likes Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    User....

    The drugs can bring benefit if people use them as intended....in conjunction with diet and exercise.

    I like Belviq as a possible smoking cessation drug. I invited in orexigen for the European approval and European partnership play.
    May 1, 2015. 11:02 AM | Likes Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    User...

    She will run. I simply do not see her getting the nomination. Baggage
    May 1, 2015. 11:00 AM | Likes Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    Jakes.....

    Obesity is not forced upon people. There are those that can not help themselves because of a medical condition, genetics, etc. these people deserve help, and deserve to have good treatment. That being said, everyone needs to step up to the plate themselves. Government should simply govern. There are far to many people with a hand stretched out that simply take, never give, and do not even try. Those people are what is wrong with the system and we now have them by the millions. Design a bill that helps those that are willing to pitch in and it could accomplish something.
    No government can afford to support everyone. We have to many people drinking the milk and to few producing it. The policies we have seen over the last number of years does not promote people helping themselves. It promotes people looking for another hand-out.

    These obesity drugs promote a false calm as well. People will see limited results unless they exercise and eat right. It is probably the main reason that the average person is on the drugs less that 3 months. The moment the going gets tough at week 12, and the weight loss flattens out, people come off of the drug. Legislation that pays for a bunch of people to take a pill for three months and then stop is not solving the problem in the way that it needs to be solved.
    May 1, 2015. 07:42 AM | Likes Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    User...

    I think Hillary is not electable. That being said,she is a improvement over Obama.
    May 1, 2015. 07:17 AM | 1 Like Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    User....

    His positive will be moving out of 1600 Pennsylvania Avenue.
    May 1, 2015. 12:31 AM | Likes Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    Jakes....

    If it is all about the dollar you should hope and pray that it does not pass. You should hope and pray that ACA gets dismantled as quickly as possible. You should hope and pray that thus nation forgets that Obama was ever born. He has destroyed any integrity this nation had, is the worst president thus nation ever had, stands for mediocrity, laziness, and handouts and the utter destruction of the middle class.

    We should not promote laziness. If people get fat and die....so be it. Why on earth should the minority that eat right and exercise right pay for a lazy majority that have become used to getting everything handed to them because we have a piss poor president? I will never route for BAD policy because of an investment I made. That makes the problem worse.

    You will be far better off with no ACA and no obesity act than you could ever be invested in these equities.

    The act that should be passed is one that would be called the "personal responsibility act"
    Apr 30, 2015. 11:02 PM | 1 Like Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    Jakes....

    vivus has not taken the correct steps yet. Why on earth would anyone assume that they will suddenly star now?

    They have been jumping up and down on every street corner in big pharma begging for a partner. No one wants to partner with them.

    Every once in a while the ugly girl at the dance turns out to be a beauty. That make movies about it. Meanwhile the other 999 are simply ugly and always will be. The odds are overwhelmingly against qsymia being the pretty girl at the dance.

    It is interesting that you champion the fact that qsymia has no partner and that is a benefit, but then champion Stendra which does have a partner. Will you argue that Pfizer gets to keep all of the Viagra revenue and that Stendra s an inferior business because the partner gets a big chunk of the money?

    There is nothing that is "wow" about Vivus other than the massive drop in valuation. Until they demonstrate that they can turn it around, I am on the sideline.
    Apr 30, 2015. 10:13 PM | 1 Like Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    Jakes.....

    The ACA will go down the toilet as soon as this nation finally gets to flush Obama down the toilet. We do not need H.R. 2415 to pass. We need quality legislation not feel good legislation. It is SAD that we need to pass legislation when what is needed is simply to eat right and exercise. It is yet another bad law among many, many, many others. We have too much government and that clown Obama has made the situation far worse.
    Apr 30, 2015. 09:20 PM | 1 Like Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    Jakes...

    The position of keeping all of the revenue is not a position the company wants to be in. They have stated for years, and continue to state that they are trying to get a partner. It is a big problem. Would a potential partner see a drug with flat sales that is third in a group of three despite the advantage of launching first as attractive? Thus far the answer is no.

    When the discussion of the possibility of a generic comes up, you say the defense is to cut the price to just above the generic and that people will want the branded drug first. Interesting thought, but the company has not made a move to get into the neighborhood of contrave for price.

    The taco example is not really accurate.

    Eisai and takeda pay for marketing, distribution, a big chunk if post marketing trials, etc.
    Apr 30, 2015. 08:25 PM | 1 Like Like |Link to Comment
  • Vivus Inks Deal To Make Qsymia More Affordable, But Will It Spur Sales? [View article]
    User.....

    These things happen every few months. The last few times have meant nothing
    Apr 30, 2015. 03:18 PM | 1 Like Like |Link to Comment
  • Arena Announces Positive Results On Pain Medication Trial - What It Means To The Equity [View article]
    Rod...

    Is she a quintiles rep? Eisai has no relation to Stendra. I can see a quintiles rep being a rep of more than one company.
    Apr 30, 2015. 09:31 AM | Likes Like |Link to Comment
  • Arena Announces Positive Results On Pain Medication Trial - What It Means To The Equity [View article]
    eng....

    There are some in development and some on the market. It is a crowded space. Essentially any pain relief med would be a competitor.
    Apr 30, 2015. 09:06 AM | Likes Like |Link to Comment
COMMENTS STATS
8,427 Comments
6,998 Likes